Vaccine

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine
pp. 139-141(3)
Authors: Trivello R.; Chiaramonte M.; Ngatchu T.; Baldo V.; Majori S.; Moschen M.E.; Simoncello I.; Renzulli G.; Naccarato R.

Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella
pp. 142-150(9)
Authors: Verma N.K.; Ziegler H.K.; Wilson M.; Khan M.; Safley S.; Stocker B.A.D.; Schoolnik G.K.

Partial protection against natural trypanosomiasis after vaccination with a flagellar pocket antigen from Trypanosoma brucei rhodesiense
pp. 151-154(4)
Authors: Mkunza F.; Olaho W.M.; Powell C.N.

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes
pp. 155-162(8)
Authors: de Haan A.; Geerligs H.J.; Huchshorn J.P.; van Scharrenburg G.J.M.; Palache A.M.; Wilschut J.

Compliance with immunization against hepatitis B. A pragmatic study in sexually transmitted disease clinics
pp. 163-167(5)
Authors: Dal-Re R.; Gonzalez A.; Ramirez V.; Ballesteros J.; del Romero J.; Bru F.

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants
pp. 168-174(7)
Authors: Migasena S.; Simasathien S.; Samakoses R.; Pitisuttitham P.; Sangaroon P.; van Steenis G.; Beuvery E.C.; Bugg H.; Bishop R.; Davidson B.L.; Vesikari T.

Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule
pp. 175-178(4)
Authors: Papaevangelou G.; Karvelis E.; Alexiou D.; Kiossoglou K.; Roumeliotou A.; Safary A.; Collard F.; Vandepapeliere P.

Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia
pp. 179-184(6)
Authors: Chhibber S.; Bajaj J.

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon- production and local IgA response
pp. 185-190(6)
Authors: Tomoda T.; Morita H.; Kurashige T.; Maassab H.F.

Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes
pp. 191-196(6)
Authors: Verger J.-M.; Grayon M.; Zundel E.; Lechopier P.; Olivier-Bernardin V.

Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses
pp. 197-201(5)
Authors: Galletti R.; Beauverger P.; Wild T.F.

Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins
pp. 202-208(7)
Authors: Vogt G.; le Grand R.; Vaslin B.; Boussin F.; Auboyer M.-H.B.; Riviere Y.; Putkonen P.; Sonigo P.; Kieny M.-P.; Girard M.; Dormont D.

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva
pp. 209-214(6)
Authors: NIAID AIDS; Gorse G.J.; Rogers J.H.; Perry J.E.; Newman F.K.; Frey S.E.; Patel G.B.; Belshe R.B.

Comparison of the susceptibility of the red fox (Vulpes vulpes) to a vaccinia-rabies recombinant virus and to cowpox virus
pp. 215-219(5)
Authors: Boulanger D.; Brochier B.; Crouch A.; Bennett M.; Gaskell R.M.; Baxby D.; Pastoret P.-P.

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults
pp. 220-224(5)
Authors: Garin D.; Vidor E.; Wallon M.; Fanget B.; Brasseur P.; Delolme H.; Caron F.; Mojon M.; Gravey A.; Humbert G.; Flehmig B.; Peyron F.

Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide
pp. 225-229(5)
Authors: Glass E.J.; Millar P.